Muutke küpsiste eelistusi

E-raamat: Childhood Cancer and Functional Impacts Across the Care Continuum

  • Formaat: 526 pages
  • Ilmumisaeg: 24-Mar-2021
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309683524
  • Formaat - EPUB+DRM
  • Hind: 116,99 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 526 pages
  • Ilmumisaeg: 24-Mar-2021
  • Kirjastus: National Academies Press
  • Keel: eng
  • ISBN-13: 9780309683524

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Since the late 1960s, the survival rate in children and adolescents diagnosed with cancer has steadily improved, with a corresponding decline in the cancer-specific death rate. Although the improvements in survival are encouraging, they have come at the cost of acute, chronic, and late adverse effects precipitated by the toxicities associated with the individual or combined use of different types of treatment (e.g., surgery, radiation, chemotherapy). In some cases, the impairments resulting from cancer and its treatment are severe enough to qualify a child for U.S. Social Security Administration disability benefits.



At the request of Social Security Administration, Childhood Cancer and Functional Impacts Across the Care Continuum provides current information and findings and conclusions regarding the diagnosis, treatment, and prognosis of selected childhood cancers, including different types of malignant solid tumors, and the effect of those cancers on children's health and functional capacity, including the relative levels of functional limitation typically associated with the cancers and their treatment. This report also provides a summary of selected treatments currently being studied in clinical trials and identifies any limitations on the availability of these treatments, such as whether treatments are available only in certain geographic areas.

Table of Contents



Front Matter Summary 1 Introduction 2 Epidemiology of Childhood Cancer in the United States 3 Treatment Modalities for Childhood Cancers 4 Childhood Cancers and Function 5 Selected Hematologic Malignancies and Histiocytoses 6 Selected Central Nervous System Tumors 7 Selected NonCentral Nervous System Solid Tumors 8 The Transition from Adolescence to Young Adulthood 9 Overall Conclusions Appendix A: Public Session Agendas Appendix B: Epidemiology and Attributes of Specific Childhood Cancers Appendix C: Selected Resources Appendix D: Biographical Sketches of Committee Members
Acronyms and Abbreviations xix
Summary 1(14)
1 Introduction
15(12)
Context for This Study
15(2)
Study Charge and Scope
17(1)
Study Approach
17(7)
Report Organization
24(1)
References
25(2)
2 Epidemiology of Childhood Cancer in the United States
27(20)
Incidence
27(7)
Mortality and Survival
34(1)
Cancer-Specific Information
35(2)
Etiologic Risk Factors
37(4)
Therapy-Related Morbidity
41(2)
Findings and Conclusions
43(1)
References
44(3)
3 Treatment Modalities For Childhood Cancers
47(80)
Pediatric Cooperative Groups
48(1)
Multimodal Therapies
48(1)
Standard Treatment Modalities
49(17)
Emerging Treatments
66(4)
Summary
70(1)
Findings and Conclusions
70(3)
References
73(54)
4 Childhood Cancers and Function
127(118)
Physical Functioning
129(36)
Cognitive Functioning
165(19)
Psychosocial and Emotional Functioning
184(6)
Summary
190(1)
Findings and Conclusions
190(3)
References
193(52)
5 Selected Hematologic Malignancies and Histiocytoses
245(30)
Overview
246(1)
Diagnosis, Prognosis, Treatment, and Outcomes by Malignancy
247(9)
Findings and Conclusions
256(1)
References
257(18)
6 Selected Central Nervous System Tumors
275(26)
Overview
275(4)
Diagnosis, Prognosis, Treatment, and Outcomes by Tumor Type
279(9)
Findings and Conclusions
288(1)
References
289(12)
7 Selected Non-Central Nervous System Solid Tumors
301(88)
Overview
302(1)
Diagnosis, Prognosis, Treatment, and Outcomes by Tumor Type
303(33)
Findings and Conclusions
336(1)
References
337(52)
8 The Transition From Adolescence to Young Adulthood
389(22)
The Disability Determination Process
390(2)
Epidemiology of Cancers in Adolescents and Young Adults
392(7)
Clinical Differences Between Adolescence and Young Adulthood
399(1)
Late Effects
400(1)
Fertility Preservation
400(1)
Functional Impacts Unique to Adolescence and Young Adulthood
401(3)
Findings and Conclusions
404(2)
References
406(5)
9 Overall Conclusions
411(24)
Overall Conclusions
411(10)
Selected Findings and Conclusions in Support of the Committee's Overall Conclusions
421(14)
APPENDIXES
A Public Session Agendas
435(4)
B Epidemiology and Attributes of Specific Childhood Cancers
439(56)
C Selected Resources
495(4)
D Biographical Sketches of Committee Members
499